• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Urgent Need for Next-Generation COVID-19 Vaccines.

作者信息

Marks Peter W, Gruppuso Philip A, Adashi Eli Y

机构信息

Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland.

Warren Alpert Medical School, Brown University, Providence, Rhode Island.

出版信息

JAMA. 2023 Jan 3;329(1):19-20. doi: 10.1001/jama.2022.22759.

DOI:10.1001/jama.2022.22759
PMID:36484995
Abstract
摘要

相似文献

1
Urgent Need for Next-Generation COVID-19 Vaccines.对下一代新冠疫苗的迫切需求
JAMA. 2023 Jan 3;329(1):19-20. doi: 10.1001/jama.2022.22759.
2
Immunogenicity and safety of SARS-CoV-2 vaccines in clinical trials.临床试验中 SARS-CoV-2 疫苗的免疫原性和安全性。
Front Biosci (Landmark Ed). 2021 Nov 30;26(11):1286-1304. doi: 10.52586/5024.
3
A booster with SARS-CoV-2 vaccines: protection against Omicron infection.一剂严重急性呼吸综合征冠状病毒2（SARS-CoV-2）疫苗加强针：预防奥密克戎感染
Signal Transduct Target Ther. 2022 Apr 5;7(1):115. doi: 10.1038/s41392-022-00973-5.
4
Cross-protective immunity following coronavirus vaccination and coronavirus infection.冠状病毒疫苗接种和感染后的交叉保护免疫。
J Clin Invest. 2021 Dec 15;131(24). doi: 10.1172/JCI151969.
5
Effectiveness of COVID-19 vaccines against Omicron variant.新冠疫苗对奥密克戎变异株的有效性。
Immunotherapy. 2022 Aug;14(12):903-904. doi: 10.2217/imt-2022-0077. Epub 2022 Jul 5.
6
The lymphatic system and COVID-19 vaccines.淋巴系统与 COVID-19 疫苗。
Front Immunol. 2022 Oct 20;13:1041025. doi: 10.3389/fimmu.2022.1041025. eCollection 2022.
7
High-Resolution Linear Epitope Mapping of the Receptor Binding Domain of SARS-CoV-2 Spike Protein in COVID-19 mRNA Vaccine Recipients.新型冠状病毒刺突蛋白受体结合域线性表位在 COVID-19 mRNA 疫苗接种者中的高分辨率线性表位作图。
Microbiol Spectr. 2021 Dec 22;9(3):e0096521. doi: 10.1128/Spectrum.00965-21. Epub 2021 Nov 10.
8
Cellular response to COVID-19 vaccines in hematologic malignancies patients: a new hope for non-responders?血液系统恶性肿瘤患者对新冠疫苗的细胞反应：无反应者的新希望？
Leuk Lymphoma. 2022 Mar;63(3):743-746. doi: 10.1080/10428194.2021.1998485. Epub 2021 Oct 28.
9
Cross-variant protection against SARS-CoV-2 infection in hamsters immunized with monovalent and bivalent inactivated vaccines.用单价和双价灭活疫苗免疫的仓鼠对 SARS-CoV-2 感染的交叉变体保护作用。
Int J Biol Sci. 2022 Jul 13;18(12):4781-4791. doi: 10.7150/ijbs.72109. eCollection 2022.
10
Current scenario of COVID-19 vaccinations and immune response along with antibody titer in vaccinated inhabitants of different countries.不同国家接种者的 COVID-19 疫苗接种现状和免疫反应及抗体滴度。
Int Immunopharmacol. 2021 Oct;99:108050. doi: 10.1016/j.intimp.2021.108050. Epub 2021 Aug 6.

引用本文的文献

1
Induction of lung mucosal immunity by a next-generation inhaled aerosol COVID-19 vaccine: an open-label, multi-arm phase 1 clinical trial.新一代吸入式气溶胶新冠疫苗诱导肺部黏膜免疫：一项开放标签、多臂1期临床试验
Nat Commun. 2025 Jul 2;16(1):6000. doi: 10.1038/s41467-025-60726-0.
2
Clinical characteristics of 909 cases infected by Omicron BF.7 variant in Hohhot of China: A retrospective study.中国呼和浩特909例感染奥密克戎BF.7变异株病例的临床特征：一项回顾性研究
Medicine (Baltimore). 2025 Jun 20;104(25):e42794. doi: 10.1097/MD.0000000000042794.
3
The rising SARS-CoV-2 JN.1 variant: evolution, infectivity, immune escape, and response strategies.
不断出现的新型严重急性呼吸综合征冠状病毒2（SARS-CoV-2）JN.1变体：进化、传染性、免疫逃逸及应对策略
MedComm (2020). 2024 Jul 29;5(8):e675. doi: 10.1002/mco2.675. eCollection 2024 Aug.
4
Preclinical assessment of a recombinant RBD-Fc fusion protein as SARS-CoV-2 candidate vaccine.重组RBD-Fc融合蛋白作为SARS-CoV-2候选疫苗的临床前评估
Eur J Microbiol Immunol (Bp). 2024 May 16;14(3):228-242. doi: 10.1556/1886.2024.00045. Print 2024 Sep 11.
5
Current Progress, Challenges and Prospects in the Development of COVID-19 Vaccines.2019冠状病毒病疫苗研发的当前进展、挑战与前景
Drugs. 2024 Apr;84(4):403-423. doi: 10.1007/s40265-024-02013-8. Epub 2024 Apr 23.
6
COVID-19 vaccines: Immune correlates and clinical outcomes.COVID-19 疫苗：免疫相关性和临床结局。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2324549. doi: 10.1080/21645515.2024.2324549. Epub 2024 Mar 22.
7
Cross-protection induced by highly conserved human B, CD4, and CD8 T-cell epitopes-based vaccine against severe infection, disease, and death caused by multiple SARS-CoV-2 variants of concern.基于高度保守的人类B细胞、CD4和CD8 T细胞表位的疫苗诱导的交叉保护作用，可抵御由多种值得关注的SARS-CoV-2变体引起的严重感染、疾病和死亡。
Front Immunol. 2024 Jan 22;15:1328905. doi: 10.3389/fimmu.2024.1328905. eCollection 2024.
8
An intranasal live-attenuated SARS-CoV-2 vaccine limits virus transmission.经鼻内接种减毒的 SARS-CoV-2 疫苗可限制病毒传播。
Nat Commun. 2024 Feb 2;15(1):995. doi: 10.1038/s41467-024-45348-2.
9
A next-generation inhalable dry powder COVID vaccine.一种下一代可吸入式干粉新冠疫苗。
Nature. 2023 Dec;624(7992):532-534. doi: 10.1038/d41586-023-03557-7.
10
Integrated antibody and cellular immunity monitoring are required for assessment of the long term protection that will be essential for effective next generation vaccine development.需要进行抗体和细胞免疫综合监测，以评估长期保护效果，这对于有效开发下一代疫苗至关重要。
Front Immunol. 2023 Nov 23;14:1166059. doi: 10.3389/fimmu.2023.1166059. eCollection 2023.